Table 1.
Varaible | Fertile control (n=58) | Patient before CoQ10 (n=65) | Patient after CoQ10 | Patient before Centrum) | Patient after Centrum |
---|---|---|---|---|---|
Age (yr) | 36.4±15.2 | 33.6±14.1 | 32.4±13.6 | ||
Infertility duration (yr) | 6.4±5.2 | 7.1±6.4 | |||
Volume (mL) | 3.1±1.6 | 3.3±1.8 | 3.5±1.6 | 3.6±2.0 | 3.6±1.7 |
Concentration (million/mL) | 50.4±27.3 | 8.9±5.1c) | 10.6±.6.4a),c) | 9.79±5.7c) | 11.8±7.0a),c) |
Progressive motility (%) | 46.1±9.7 | 20.8±8.4c) | 25.7±12.5b),c) | 22.9±9.3c) | 30.2±13.6b),c),d) |
Total motility (%) | 63.5±12.6 | 28.8±8.2c) | 35.1±14.6a),c) | 31.6±9.2c) | 41.4±16.2a),c),d) |
Normal morphology (%) | 6.3±2.9 | 2.7±2.1c) | 3.3±1.6c) | 2.5±1.3c) | 3.7±1.6c) |
Values are presented as mean±standard deviation.
CoQ10, coenzyme Q10.
vs. patients before CoQ10, p<0.05;
vs. patients before CoQ10, p<0.01;
vs. fertile control group, p<0.001;
vs. patients after CoQ10, p<0.05.